Privia Health Group, Inc.
Profit after direct costs
Core business profitability
Bottom line profitability
Top line growth rate
Flow of revenue through cost categories to net income
| Item | Trend | 2021 | 2022 | 2023 | 2024 | 2025 | YoY Change |
|---|---|---|---|---|---|---|---|
Total Revenue | 966.22M | 1.36B | 1.66B | 1.74B | 2.12B | 22.3% | |
| Cost of Revenue | (902.56M) | (1.22B) | (1.50B) | (1.56B) | (1.91B) | 22.7% | |
Gross Profit | 63.66M | 134.78M | 161.50M | 176.85M | 209.43M | 18.4% | |
| Operating Expenses | |||||||
| Research & Development | — | — | — | — | — | — | |
| Selling, General & Administrative | (278.63M) | (149.33M) | (134.32M) | (152.60M) | (165.29M) | 8.3% | |
| General & Administrative | (255.88M) | (129.59M) | (109.59M) | (126.16M) | (138.15M) | 9.5% | |
| Selling & Marketing | (22.75M) | (19.74M) | (24.73M) | (26.45M) | (27.14M) | 2.6% | |
| Depreciation & Amortization | (2.46M) | (4.57M) | (6.53M) | (7.27M) | (9.91M) | 36.3% | |
Operating Income (EBIT) | -217.44M | -19.12M | 20.65M | 16.98M | 34.23M | 101.6% | |
| Non-Operating Items | |||||||
| Interest Income | — | 542.00K | 8.37M | 10.89M | 9.70M | -10.9% | |
| Interest Expense | (1.07M) | — | — | — | — | — | |
| Other Income/Expenses (Net) | -1.07M | 542.00K | 8.37M | 10.89M | 9.70M | -10.9% | |
Income Before Tax | -218.51M | -18.58M | 29.02M | 27.87M | 43.94M | 57.7% | |
| Income Tax Expense | (27.86M) | (6.52M) | (7.99M) | (10.83M) | (14.21M) | 31.3% | |
Net Income | -188.23M | -8.59M | 23.08M | 14.38M | 22.92M | 59.3% | |
| Per Share Metrics | |||||||
| Earnings Per Share (Basic) | $-2 | $-0 | $0 | $0 | $0 | 58.3% | |
| Weighted Avg Shares Outstanding | 107.84M | 110.70M | 116.73M | 119.40M | 122.18M | 2.3% | |
| Weighted Avg Shares Outstanding (Diluted) | 107.84M | 110.70M | 124.69M | 125.61M | 128.89M | 2.6% | |
EBITDA | -214.97M | -14.01M | 35.55M | 35.14M | 53.84M | 53.2% |
Explore PRVA
PRVA in the Healthcare
Mid Cap